Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

August 01, 1994; Volume 46,Issue 2
  • You have access
    Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
    J W Regan, T J Bailey, D J Pepperl, K L Pierce, A M Bogardus, J E Donello, C E Fairbairn, K M Kedzie, D F Woodward and D W Gil
    Molecular Pharmacology August 1994, 46 (2) 213-220;
  • You have access
    Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification.
    D T Price, R S Chari, D E Berkowitz, W C Meyers and D A Schwinn
    Molecular Pharmacology August 1994, 46 (2) 221-226;
  • You have access
    Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.
    J D Kursar, D L Nelson, D B Wainscott and M Baez
    Molecular Pharmacology August 1994, 46 (2) 227-234;
  • You have access
    Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP.
    R V Benya, Z Fathi, T Kusui, T Pradhan, J F Battey and R T Jensen
    Molecular Pharmacology August 1994, 46 (2) 235-245;
  • You have access
    Cloning and characterization of an abundant subtype of the human calcitonin receptor.
    R E Kuestner, R D Elrod, F J Grant, F S Hagen, J L Kuijper, S L Matthewes, P J O'Hara, P O Sheppard, S D Stroop and D L Thompson
    Molecular Pharmacology August 1994, 46 (2) 246-255;
  • You have access
    Ligand binding characterization and molecular analysis of distinct epidermal growth factor-urogastrone receptors in cultured smooth muscle and epithelial cells from guinea pig intestine.
    S G Yang, S Ahmad, N C Wong and M D Hollenberg
    Molecular Pharmacology August 1994, 46 (2) 256-265;
  • You have access
    Protein kinase C mediates delayed inhibitory feedback regulation of human neurokinin type 1 receptor activation of phospholipase C in UC11 astrocytoma cells.
    A J Barr and S P Watson
    Molecular Pharmacology August 1994, 46 (2) 266-273;
  • You have access
    Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells.
    T Scott-Burden, E Elizondo, T Ge, C M Boulanger and P M Vanhoutte
    Molecular Pharmacology August 1994, 46 (2) 274-282;
  • You have access
    Human cyclic GMP-dependent protein kinase I beta overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response.
    M Meinecke, J Geiger, E Butt, M Sandberg, T Jahnsen, T Chakraborty, U Walter, T Jarchau and S M Lohmann
    Molecular Pharmacology August 1994, 46 (2) 283-290;
  • You have access
    Characterization of cloned human somatostatin receptor SSTR5.
    A M O'Carroll, K Raynor, S J Lolait and T Reisine
    Molecular Pharmacology August 1994, 46 (2) 291-298;
  • You have access
    Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.
    A Malmberg, G Nordvall, A M Johansson, N Mohell and U Hacksell
    Molecular Pharmacology August 1994, 46 (2) 299-312;
  • You have access
    Sequence-selective binding to DNA of cis- and trans- butamidine analogues of the anti-Pneumocystis carinii pneumonia drug pentamidine.
    C Bailly, I O Donkor, D Gentle, M Thornalley and M J Waring
    Molecular Pharmacology August 1994, 46 (2) 313-322;
  • You have access
    Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.
    T Khélifa, M R Casabianca-Pignède, B René and A Jacquemin-Sablon
    Molecular Pharmacology August 1994, 46 (2) 323-328;
  • You have access
    Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin.
    D I Morris, L M Greenberger, E P Bruggemann, C Cardarelli, M M Gottesman, I Pastan and K B Seamon
    Molecular Pharmacology August 1994, 46 (2) 329-337;
  • You have access
    Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.
    J A Hasler, G R Harlow, G D Szklarz, G H John, K M Kedzie, V L Burnett, Y A He, L S Kaminsky and J R Halpert
    Molecular Pharmacology August 1994, 46 (2) 338-345;
  • You have access
    Peroxidase activity in murine and human hematopoietic progenitor cells: potential relevance to benzene-induced toxicity.
    D G Schattenberg, W S Stillman, J J Gruntmeir, K M Helm, R D Irons and D Ross
    Molecular Pharmacology August 1994, 46 (2) 346-351;
  • You have access
    High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains.
    S W Robinson, K R Jarvie and M G Caron
    Molecular Pharmacology August 1994, 46 (2) 352-356;
  • You have access
    Characterization of a new, highly specific, beta 3-adrenergic receptor radioligand, [3H]SB 206606.
    P Muzzin, O Boss, N Mathis, J P Revelli, J P Giacobino, K Willcocks, G T Badman, B C Cantello, R M Hindley and M A Cawthorne
    Molecular Pharmacology August 1994, 46 (2) 357-363;
  • You have access
    Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes.
    V Asghari, O Schoots, S van Kats, K Ohara, V Jovanovic, H C Guan, J R Bunzow, A Petronis and H H Van Tol
    Molecular Pharmacology August 1994, 46 (2) 364-373;
  • You have access
    Binding of [26-3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes.
    M G Kazanietz, N E Lewin, F Gao, G R Pettit and P M Blumberg
    Molecular Pharmacology August 1994, 46 (2) 374-379;
  • You have access
    Attenuation of agonist-induced desensitization of the rat substance P receptor by microinjection of inositol pentakis-and hexakisphosphates in Xenopus laevis oocytes.
    N Sasakawa, J E Ferguson, M Sharif and M R Hanley
    Molecular Pharmacology August 1994, 46 (2) 380-385;
  • You have access
    Thermodynamics of gamma-aminobutyric acid type A receptor binding differentiate agonists from antagonists.
    G Maksay
    Molecular Pharmacology August 1994, 46 (2) 386-390;
  • You have access
    Nitric oxide production during endotoxic shock in carbon tetrachloride-treated rats.
    W Chamulitrat, S J Jordan and R P Mason
    Molecular Pharmacology August 1994, 46 (2) 391-397;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 46, Issue 2
1 Aug 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Nelfinavir and PXR
  • Wnt Signaling and Drug Resistance in Cancer
  • Coronavirus in the Brain and the Impact of Smoking
  • Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics